Reading and writing the code of life.

Mammoth Biosciences is a diagnostics company that has developed a CRISPR-based detection platform capable of sensing any biomarker or disease with DNA/RNA. The company is co-founded by CRISPR pioneer Jennifer Doudna, Stanford PhD Trevor Martin, and Berkeley PhDs Janice Chen and Lucas Harrington. Mammoth is on a mission to leverage the power of CRISPR to democratize disease detection by bringing accurate and affordable testing out of the laboratory to the point-of-care.